n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with transforming growth factor beta in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 11 (78.57) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kennedy, BP; Pruzanski, W; Stefanski, E; Vadas, P; van den Bosch, H | 1 |
| Koide, M; Murase, Y; Nishihara, T; Noguchi, T; Okahashi, N; Yamato, K | 1 |
| Crew, TE; Elder, DJ; Paraskeva, C | 1 |
| Boyan, BD; Cochran, DL; Dean, DD; Liu, Y; Lohmann, CH; Schwartz, Z; Sisk, M; Sylvia, VL | 1 |
| LaPointe, MC; Leung, A; Mendez, M; Tao, Z; Yang, XP | 1 |
| Bradbury, D; Clayton, A; El-Haroun, H; Knox, AJ | 1 |
| Hwang, SM; Lin, CH; Lin, CY; Shen, YH; Tsai, YC; Wu, SH | 1 |
| Arikawa, T; Morita, I; Omura, K | 1 |
| Dannenberg, AJ; Du, B; Friedman, SL; Hui, AY; Olinga, P; Subbaramaiah, K; Sung, JJ | 1 |
| Bradbury, D; Corbett, L; Knox, AJ; Pang, L; Stocks, J | 1 |
| Cummins, J; Huard, J; Li, Y; Shen, W; Tang, Y | 1 |
| Choi, ME; Hiraga, T; Myoui, A; Yoneda, T; Yoshikawa, H | 1 |
| Balasubramanian, L; Glass, WF; Harding, P; Stevens, A; Swegan, J | 1 |
| Chen, X; Fan, Y; Guo, N; Han, J; Yang, B; Zhang, L | 1 |
14 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and transforming growth factor beta
| Article | Year |
|---|---|
Regulation of the cellular expression of secretory and cytosolic phospholipases A2, and cyclooxygenase-2 by peptide growth factors.
Topics: Animals; Antineoplastic Agents; Becaplermin; Blotting, Western; Cells, Cultured; Cycloheximide; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytosol; Dinoprostone; Dose-Response Relationship, Drug; Epidermal Growth Factor; Fibroblast Growth Factor 1; Fibroblast Growth Factor 2; Gene Expression; Granulocyte-Macrophage Colony-Stimulating Factor; Interferon-gamma; Interleukin-1; Isoenzymes; Nitrobenzenes; Osteoblasts; Phospholipases A; Platelet-Derived Growth Factor; Prostaglandin-Endoperoxide Synthases; Protein Synthesis Inhibitors; Proto-Oncogene Proteins c-sis; Rats; Rats, Wistar; RNA, Messenger; Sulfonamides; Time Factors; Transcription, Genetic; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 1998 |
Bone morphogenetic protein-2 enhances osteoclast formation mediated by interleukin-1alpha through upregulation of osteoclast differentiation factor and cyclooxygenase-2.
Topics: Activins; Animals; Bone Development; Bone Marrow Cells; Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Carrier Proteins; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Gene Expression Regulation, Developmental; Indomethacin; Inhibins; Interleukin-1; Isoenzymes; Membrane Glycoproteins; Mice; Mice, Inbred Strains; Nitrobenzenes; Osteoclasts; Prostaglandin-Endoperoxide Synthases; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; RNA, Messenger; Sulfonamides; Transforming Growth Factor beta; Up-Regulation | 1999 |
A cyclooxygenase-2 (COX-2) selective non-steroidal anti-inflammatory drug enhances the growth inhibitory effect of butyrate in colorectal carcinoma cells expressing COX-2 protein: regulation of COX-2 by butyrate.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Apoptosis; Butyrates; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Drug Synergism; Humans; Isoenzymes; Membrane Proteins; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Rats; Sulfonamides; Transforming Growth Factor beta; Tumor Cells, Cultured; Up-Regulation | 2000 |
Both cyclooxygenase-1 and cyclooxygenase-2 mediate osteoblast response to titanium surface roughness.
Topics: Alkaline Phosphatase; Biocompatible Materials; Cell Line; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Humans; Indomethacin; Isoenzymes; Materials Testing; Membrane Proteins; Nitrobenzenes; Osteoblasts; Osteocalcin; Phenotype; Prostaglandin-Endoperoxide Synthases; Resveratrol; Stilbenes; Sulfonamides; Surface Properties; Titanium; Transforming Growth Factor beta | 2001 |
Inhibition of cyclooxygenase-2 improves cardiac function after myocardial infarction in the mouse.
Topics: Animals; Cardiomegaly; Collagen; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Echocardiography; Fibrosis; Heart; Immunohistochemistry; Isoenzymes; Lactones; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Myocardium; Natriuretic Peptide, Brain; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Reverse Transcriptase Polymerase Chain Reaction; Sulfonamides; Sulfones; Transforming Growth Factor beta | 2004 |
Interleukin-1beta, transforming growth factor-beta1, and bradykinin attenuate cyclic AMP production by human pulmonary artery smooth muscle cells in response to prostacyclin analogues and prostaglandin E2 by cyclooxygenase-2 induction and downregulation o
Topics: Adenylyl Cyclases; Adult; Arachidonic Acid; Bradykinin; Cells, Cultured; Colforsin; Cyclic AMP; Cyclooxygenase 2; Dinoprostone; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Induction; Epoprostenol; Gene Expression Regulation, Enzymologic; Growth Substances; Humans; Interleukin-1; Isoenzymes; Isoproterenol; Membrane Proteins; Muscle, Smooth, Vascular; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Prostaglandins; Pulmonary Artery; RNA, Messenger; Sulfonamides; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
Effect of bismuth subgallate on nitric oxide and prostaglandin E2 production by macrophages.
Topics: Animals; Blotting, Northern; Blotting, Western; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Escherichia coli; Gallic Acid; Interferon-gamma; Isoenzymes; Lipopolysaccharides; Macrophages; Mice; Nitric Oxide; Nitric Oxide Donors; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitrobenzenes; Nitroprusside; Organometallic Compounds; Prostaglandin-Endoperoxide Synthases; Recombinant Proteins; RNA, Messenger; Sulfonamides; Transforming Growth Factor beta | 2004 |
Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells.
Topics: Bone Morphogenetic Protein 2; Bone Morphogenetic Proteins; Cell Differentiation; Cells, Cultured; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Gene Expression Regulation, Developmental; Humans; Isoenzymes; Membrane Proteins; Mesenchymal Stem Cells; Mesoderm; Nitrobenzenes; Osteoblasts; Osteogenesis; Prostaglandin-Endoperoxide Synthases; Receptors, Prostaglandin E; Receptors, Prostaglandin E, EP4 Subtype; Sulfonamides; Transforming Growth Factor beta | 2004 |
Prostaglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells.
Topics: Animals; Cell Line, Transformed; Collagen Type I; Collagen Type I, alpha 1 Chain; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; DNA-Binding Proteins; Heat-Shock Proteins; Humans; Isoenzymes; Liver; Membrane Proteins; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Receptors, Prostaglandin E; RNA, Messenger; Serpins; Smad Proteins; Sulfonamides; Trans-Activators; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
Cytokines upregulate vascular endothelial growth factor secretion by human airway smooth muscle cells: Role of endogenous prostanoids.
Topics: Blotting, Western; Cell Survival; Cells, Cultured; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytokines; Dactinomycin; Dinoprostone; Dose-Response Relationship, Drug; Enzyme Induction; Humans; Indomethacin; Interleukin-1; Kinetics; Luciferases; Membrane Proteins; Muscle, Smooth; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; RNA, Messenger; Sulfonamides; Trachea; Transforming Growth Factor beta; Up-Regulation; Vascular Endothelial Growth Factor A | 2005 |
NS-398, a cyclooxygenase-2-specific inhibitor, delays skeletal muscle healing by decreasing regeneration and promoting fibrosis.
Topics: Animals; Antibodies, Monoclonal; Blotting, Western; Cell Culture Techniques; Cell Differentiation; Cell Extracts; Cell Proliferation; Cells, Cultured; Collagen; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Fibrosis; Flow Cytometry; Fluorescein; Fluorescein-5-isothiocyanate; Fluorescent Antibody Technique, Direct; Fluorescent Dyes; Immunohistochemistry; Indoles; Kinetics; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Models, Anatomic; Muscle, Skeletal; Myostatin; Nitrobenzenes; Regeneration; Staining and Labeling; Stem Cells; Sulfonamides; Transforming Growth Factor beta; Transforming Growth Factor beta1; Wound Healing | 2005 |
Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer.
Topics: Animals; Apoptosis; Bone and Bones; Bone Neoplasms; Breast Neoplasms; Cell Line, Tumor; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Female; Heart Ventricles; Humans; Mice; Neoplasm Transplantation; Nitrobenzenes; Osteoclasts; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Recombinant Proteins; Sulfonamides; Transforming Growth Factor beta; Transplantation, Heterologous; Up-Regulation | 2006 |
Transforming growth factor beta regulates cyclooxygenase-2 in glomerular mesangial cells.
Topics: Animals; Collagen Type I; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Gene Expression Regulation, Enzymologic; Humans; Kidney Glomerulus; Mesangial Cells; NF-kappa B; Nitrobenzenes; Promoter Regions, Genetic; Prostaglandin-E Synthases; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; RNA Stability; RNA, Messenger; Sulfonamides; Transcription Factor AP-1; Transcription, Genetic; Transforming Growth Factor beta | 2006 |
Effects of all-trans retinoic acid on signal pathway of cyclooxygenase-2 and Smad3 in transforming growth factor-β-stimulated glomerular mesangial cells.
Topics: Animals; Apoptosis; Cell Line; Cell Proliferation; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Dinoprostone; Fibrosis; Glomerular Mesangium; Mesangial Cells; Nitrobenzenes; Protein Transport; Rats; RNA, Messenger; Signal Transduction; Smad3 Protein; Smad7 Protein; Staurosporine; Sulfonamides; Thromboxane A2; Transforming Growth Factor beta; Tretinoin | 2014 |